{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:41:04Z","timestamp":1782866464400,"version":"3.54.5"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> To investigate the mechanism of activation of the signal transducer and activator of transcription 3 (STAT3) signal pathway in the process of retinopathy of prematurity (ROP).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Sixty newborn Sprague-Dawley (SD) rats were randomly separated into the hyperoxia and air control groups (<jats:italic>n<\/jats:italic> = 30\/in each group). The serum hepcidin level on 21 d was measured using the enzyme-linked immunosorbent assay (ELISA). The expression of HAMP and STAT3 protein in the liver was determined using reverse transcription-polymerase chain reaction (RT-PCR) and western blotting. Retinal neovasculature was evaluated by hematoxylin and eosin (HE) stain and fluorescein lectin. The retinal endothelial cells were treated with 250 \u03bcmol\/L cobalt chloride for 72 h and added S3I-201. The STAT3 level was determined by western blotting.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The expression of STAT3 protein increased significantly after hyperoxia stimulation. The expression of HAMP mRNA in the hyperoxia group was significantly higher than that of the control group. The proliferation of retinal cells was inhibited, and the expression of STAT3 was increased. No significant difference was noted in vascular endothelial growth factor (VEGF) mRNA. The expression of STAT3 and VEGF mRNA was significantly reduced.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The activation of the STAT3 signal pathway increased hepcidin expression, contributing to the pathogenesis of ROP. S3I-201 inhibited the expression of STAT3 and VEGF mRNA levels. This information provides potential novel therapeutic approach to the prevention and treatment of ROP.<\/jats:p>","DOI":"10.3389\/fped.2021.638432","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T10:00:44Z","timestamp":1636538444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The Effect of STAT3 Signal Pathway Activation on Retinopathy of Prematurity"],"prefix":"10.3389","volume":"9","author":[{"given":"Jianbing","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqiong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longkai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.18043\/ncm.78.2.124","article-title":"Retinopathy of prematurity","volume":"78","author":"Bashinsky","year":"2017","journal-title":"N Carolina Med J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s12098-017-2404-3","article-title":"An update on retinopathy of prematurity (ROP)","volume":"84","author":"Dogra","year":"2017","journal-title":"Indian J Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3969\/j.issn.1673-5501.2015.03.001","article-title":"Multicenter survey on the clinical features and fundus lesions of retinopathy in premature infants in mainland China","volume":"10","year":"2015","journal-title":"Chin J Evid Based Pediatr."},{"key":"B4","first-page":"336","article-title":"Prediction of severe retinopathy of prematurity using the WINROP algorithm in a cohort from Malopolska. A retrospective, single-center study","volume":"21","author":"Jag\u0142a","year":"2017","journal-title":"Dev Period Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/ANC.0b013e3181e94176","article-title":"A data-driven approach to retinopathy of prematurity prevention leads to dramatic change","volume":"10","author":"Janet E","year":"2010","journal-title":"Adv Neonatal Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.clp.2013.02.002","article-title":"The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment","volume":"40","author":"Smith","year":"2013","journal-title":"Clin Perinatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/NPM-190336","article-title":"Perinatal events predicting retinopathy of prematurity in extremely pre-trem infants","volume":"13","author":"Alryalat","year":"2020","journal-title":"J Neonatal Perinatal Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3928\/01913913-20140220-05","article-title":"The importance of oxygen control reaffirmed: experience of ROP reduction at a single tertiary care center","volume":"51","author":"Stefano","year":"2014","journal-title":"J Pediatr Ophthalmol Strabismus."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1080\/02713683.2016.1264607","article-title":"Comparison of intravitreal bevacizumab, intravitreal ranibizumab and laser photocoagulation for treatment of type 1 retinopathy of prematurity in Turkish preterm children","volume":"42","author":"Kabata\u015f","year":"2017","journal-title":"Curr Eye Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1053\/j.semperi.2015.12.006","article-title":"Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity","volume":"40","author":"Beharry","year":"2016","journal-title":"Semin Perinatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e20153387","DOI":"10.1542\/peds.2015-3387","article-title":"Interventions to prevent retinopathy of prematurity: a meta-analysis","volume":"137","author":"Fang","year":"2016","journal-title":"Pediatrics."},{"key":"B13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10792-019-01208-3","article-title":"Intravitreal bevacizumab injection in aggressive posterior retinopathy of prematurity compared with type I retinopathy of prematurity","volume":"40","author":"Eftekhari Milani","year":"2020","journal-title":"Int Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00109-017-1551-3","article-title":"Cellular citrate levels establish a regulatory link between energy metabolism and the hepatic iron hormone hepcidin","volume":"95","author":"Da Silva","year":"2017","journal-title":"J Mol Med."},{"key":"B15","first-page":"305","article-title":"IL-6 - STAT-3 - hepcidin: linking inflammation to the iron metabolism","volume":"45","author":"Stoian","year":"2007","journal-title":"Rom J Intern Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3969\/j.issn.2095-9400.2019.05.004","article-title":"The design, synthesis and biological activity of small molecule inhibitors targeting STAT3 signaling pathway","volume":"49","author":"He","year":"2019","journal-title":"J Wezhou Med Univ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.6023\/cjoc201602030","article-title":"Design, synthesis and biological evaluation of small-molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway","volume":"36","author":"Gao","year":"2016","journal-title":"Chin J Organ Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jot.2019.07.007","article-title":"Genistein inhibits angiogenesis developed during rheumatoid arthritis through the IL-6\/JAK2\/STAT3\/VEGF signalling pathway","volume":"22","author":"Cheng","year":"2020","journal-title":"J Orthop Translat."},{"key":"B19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.7620\/zgfybj.j.issn.1001-4411.2019.02.04","article-title":"Study on expression levels of STAT3, MMPs, and VEGF in patients with endometriosis","volume":"34","author":"Cui","year":"2019","journal-title":"Matern Child Health Care China."},{"key":"B20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3321\/j.issn:1000-3282.2004.05.008","article-title":"Regulation of human VEGF by expression latent membrane protein 1 encoded by EB virus via STAT3 in nasopharyngeal carcinoma cell line","volume":"5","author":"Tan","year":"2004","journal-title":"Prog Biochem Biophys."},{"key":"B21","first-page":"119","article-title":"The iron-binding properties of fermodulin","volume":"24","author":"Devi","year":"1987","journal-title":"Indian J Biochem Biophys."},{"key":"B22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0003-9861(85)90697-6","article-title":"Purification and characterization of fermodulin, an Fe2+-dependent inhibitor protein of 3-hydroxy-3-methylglutaryl-CoA reductase","volume":"239","author":"Menon","year":"1985","journal-title":"Arch Biochem Biophys."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/eye.2017.76","article-title":"Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study","volume":"31","author":"Stutchfield","year":"2017","journal-title":"Eye (Lond)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene."},{"key":"B25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/02713680500507281","article-title":"The relationship of retinal VEGF and retinal IGF-lmRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity","volume":"31","author":"Leske","year":"2006","journal-title":"Curr Eye Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog Retinal Eye Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1167\/iovs.08-3256","article-title":"The role of supplemental oxygen and JAK\/STAT signaling in intravitreous neovascularization in a ROP rat model","volume":"50","author":"Byfield","year":"2009","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B29","first-page":"2048","article-title":"Research progress on the relationship between iron overload related diseases and hepcidin","volume":"37","author":"Liu","year":"2016","journal-title":"Guangdong Med J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth Factors (Chur, Switzerland)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3969\/j.issn.1672-4992.2018.02.039","article-title":"Inhibitors of JAK\/ STAT signaling pathway and lung cance","volume":"26","author":"Gu","year":"2018","journal-title":"J Mod Oncol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.638432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T10:00:51Z","timestamp":1636538451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.638432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":31,"alternative-id":["10.3389\/fped.2021.638432"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.638432","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"article-number":"638432"}}